Cargando…
Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atria...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298543/ https://www.ncbi.nlm.nih.gov/pubmed/34317211 http://dx.doi.org/10.1016/j.jaccas.2019.10.042 |